title: Erratum to: Switching to Omnitrope(®) from Other Recombinant Human Growth Hormone Therapies: A Retrospective Study in an Integrated Healthcare System.
authors.affiliation: Kaiser Permanente, Southern California Region, Drug Information Services, Downey, CA, USA. Nazia.X.Rashid@kp.org.
authors.forename: Nazia
authors.initials: N
authors.lastname: Rashid
authors.affiliation: Department of Pediatrics, Albert Einstein College of Medicine, New York, NY, USA.
authors.forename: Paul
authors.initials: P
authors.lastname: Saenger
authors.affiliation: Department of Research and Evaluation, Kaiser Permanente, Pasadena, CA, USA.
authors.forename: Yi-Lin
authors.initials: YL
authors.lastname: Wu
authors.affiliation: Sandoz International GmbH, Holzkirchen, Germany.
authors.forename: Heike
authors.initials: H
authors.lastname: Woehling
authors.affiliation: Sandoz Inc., Princeton, NJ, USA.
authors.forename: Matthew
authors.initials: M
authors.lastname: Frankel
authors.affiliation: Pediatric Sunshine Academics, Santa Barbara, CA, USA.
authors.forename: Fima
authors.initials: F
authors.lastname: Lifshitz
authors.affiliation: Sandoz International GmbH, Holzkirchen, Germany.
authors.forename: Michael
authors.initials: M
authors.lastname: Muenzberg
authors.affiliation: Department of Pediatrics, Mount Sinai College of Medicine, New York, NY, USA.
authors.forename: Robert
authors.initials: R
authors.lastname: Rapaport